Chemotherapy and immunotherapy before surgery for esophageal cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial compares the current standard treatment (chemotherapy and radiation) with a newer approach that combines chemotherapy and immunotherapy before surgery for esophageal cancer. Participation may help determine if this new combination is more effective for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with squamous cell carcinoma of the esophagus.
- Your cancer is at a stage where surgery is a treatment option.
- You have not had any prior cancer treatment for this condition.
- You are generally active and can care for yourself (ECOG 0-1).
- You are not pregnant or breastfeeding.
- You have not had other cancer in the last 5 years, except for certain skin cancers.
- Your doctors believe surgery is a good option for you.
- You do not have any other serious health conditions that would limit your life expectancy.
- You do not have allergies to the study drugs.
- You have not had immunotherapy or any of the study drugs before.
- You have not had surgery that would prevent you from receiving the study drugs.
- You are not hospitalized for more than 30 days in the past year (this is a proxy for overall health).
- You are not hospitalized for more than 14 days in the past year (this is a proxy for your performance status).
- You have not had any prior treatment for esophageal cancer.
- Your swallowing is not severely impaired.
- You have not had any weight loss greater than 10% in the past 3 months.
- You have not had a heart attack or stroke in the past 6 months.
- You do not have uncontrolled high blood pressure or diabetes.
- You are not enrolled in another clinical trial.
- You are not receiving any other investigational drugs.
- You are not pregnant or breastfeeding.
- You agree to use contraception during the study.
- You are willing and able to give informed consent.
- You are willing to comply with the study procedures.
- You have not had a blood transfusion in the past 2 weeks.
- You have not had surgery in the past 4 weeks.
- You have not had any other cancer treatment in the past 4 weeks.
- You have not had radiation to your chest or neck in the past 6 months.
- You have not had any autoimmune disease.
- You have not had an organ transplant.
- You have not had a weakened immune system.
- You have not had a live vaccine in the past 30 days.
- You have not had a severe infection in the past 2 weeks.
- You have not had a fracture in the past 6 months.
- You have not had a blood clot in the past 6 months.
- You have not had any bleeding problems.
- You have not had heart problems.
- You have not had lung problems.
- You have not had liver problems.
- You have not had kidney problems.
- You have not had thyroid problems.
- You have not had diabetes.
- You have not had a stroke.
- You have not had seizures.
- You have not had a mental illness.
- You have not had a drug or alcohol addiction.
- You have not been admitted to the hospital for more than 30 days in the past year.
- You have not been admitted to the hospital for more than 14 days in the past year.
- You have not had a solid organ transplant.
- You have not had a history of inflammatory bowel disease.
- You have not had a history of pulmonary fibrosis.
- You have not had a history of interstitial lung disease.
- You have not had a history of severe renal impairment.
- You have not had a history of severe hepatic impairment.
- You have not had a history of hepatitis B or C.
- You have not had a history of tuberculosis.
- You have not had a history of HIV.
- You have not had a history of a serious infection.
- You have not had a history of a major surgery within the past 4 weeks.
- You have not had a history of a severe trauma within the past 4 weeks.
- You have not had a history of a bleeding disorder.
- You have not had a history of a clotting disorder.
- You have not had a history of a stroke or TIA within the past 6 months.
- You have not had a history of a heart attack within the past 6 months.
- You have not had a history of heart failure.
- You have not had a history of an arrhythmia.
- You have not had a history of a heart valve problem.
- You have not had a history of a chest tube.
- You have not had a history of a lung biopsy.
- You have not had a history of a bronchoscopy.
- You have not had a history of an endoscopy.
- You have not had a history of a biopsy of the esophagus.
- You have not had a history of a stent in the esophagus.
- You have not had a history of radiation therapy to the chest.
- You have not had a history of chemotherapy.
- You have not had a history of immunotherapy.
- You have not had a history of targeted therapy.
- You have not had a history of surgery for esophageal cancer.
- You have not had a history of an allergy to the study drugs.
- You have not had a history of anaphylaxis.
- You have not had a history of a severe skin reaction.
- You have not had a history of a pulmonary embolism.
- You have not had a history of a deep vein thrombosis.
- You have not had a history of a pulmonary hemorrhage.
- You have not had a history of a gastrointestinal hemorrhage.
- You have not had a history of a perforation of the gastrointestinal tract.
- You have not had a history of a fistula.
- You have not had a history of an abscess.
- You have not had a history of a fistula.
- You have not had a history of a perforation.
- You have not had a history of a small bowel obstruction.
- You have not had a history of a large bowel obstruction.
- You have not had a history of a bowel perforation.
- You have not had a history of a bowel obstruction.
- You have not had a history of a perforated ulcer.
- You have not had a history of a gastric ulcer.
- You have not had a history of a duoden
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding two immunotherapy drugs to standard chemotherapy and radiation before surgery can help shrink esophageal cancer and improve outcomes. It is for people with a certain type of esophageal cancer that can be removed with surgery.
This study tests a new combination approach before surgery for esophageal cancer. You would receive a short course of radiation together with an immunotherapy drug called serplulimab and standard chemotherapy, to see if it helps shrink the tumor and improve outcomes.
This trial tests whether giving immunotherapy after surgery can help prevent cancer from returning in patients with esophageal squamous cell carcinoma. It is for people who have already received chemotherapy and immunotherapy before surgery and had surgery to remove the cancer, but still had some cancer cells found in the removed tissue.
This trial tests a combination of short-course radiation, an immunotherapy drug called tislelizumab, and chemotherapy before surgery for esophageal cancer that has spread to nearby lymph nodes but hasn't spread to distant organs. The goal is to shrink the tumor before surgery and improve outcomes.
This trial tests a treatment plan that combines immunotherapy with chemotherapy before possible endoscopic surgery. It is for people with a specific type of esophageal cancer that has not been treated before and is either potentially removable or not suitable for standard surgery.
This trial compares two treatments given before surgery for esophageal cancer. One combines an immunotherapy drug (Toripalimab) with chemotherapy (nab-paclitaxel and platinum). The other uses a different standard chemotherapy regimen (DCF). The goal is to see which is better at shrinking tumors and improving outcomes for patients with resectable, locally advanced esophageal squamous cell carcinoma.
Hear when a new Esophageal Squamous Cell Carcinoma (ESCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.